Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma have?
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma has 417 citations in the OpenAlex counts ScholarIQ stores.
When was Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma published?
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma has 2021 year in the ScholarIQ index.
What is the open-access status of Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma?
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma has gold oa status in the ScholarIQ index.
What is the DOI of Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma?
The DOI for Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma is on the source record.
What is the PMID of Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma?
The PMID for Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma is on the source record.
What is the OpenAlex record for Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma?
The OpenAlex for Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma is on the source record.